CH677796A5 - - Google Patents

Download PDF

Info

Publication number
CH677796A5
CH677796A5 CH2545/87A CH254587A CH677796A5 CH 677796 A5 CH677796 A5 CH 677796A5 CH 2545/87 A CH2545/87 A CH 2545/87A CH 254587 A CH254587 A CH 254587A CH 677796 A5 CH677796 A5 CH 677796A5
Authority
CH
Switzerland
Prior art keywords
monoclonal antibody
antibodies
flagella
antibody
type
Prior art date
Application number
CH2545/87A
Other languages
German (de)
English (en)
Inventor
Mark E Lostrom
Anthony W Siadak
Mae Joanne Rosok
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/946,554 external-priority patent/US4834976A/en
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of CH677796A5 publication Critical patent/CH677796A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CH2545/87A 1986-07-03 1987-07-03 CH677796A5 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88198486A 1986-07-03 1986-07-03
US06/946,554 US4834976A (en) 1986-07-03 1986-12-24 Monoclonal antibodies to pseudomonas aeruginosa flagella
US4814387A 1987-05-15 1987-05-15

Publications (1)

Publication Number Publication Date
CH677796A5 true CH677796A5 (fr) 1991-06-28

Family

ID=27367280

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2545/87A CH677796A5 (fr) 1986-07-03 1987-07-03

Country Status (19)

Country Link
JP (1) JP2639422B2 (fr)
KR (1) KR910002373B1 (fr)
AT (1) AT399885B (fr)
AU (1) AU615162B2 (fr)
BE (1) BE1000743A3 (fr)
CH (1) CH677796A5 (fr)
DE (1) DE3722098C2 (fr)
DK (1) DK172840B1 (fr)
ES (1) ES2013321A6 (fr)
FR (1) FR2601458B1 (fr)
GB (1) GB2192185B (fr)
IE (1) IE60888B1 (fr)
IL (1) IL83047A (fr)
IT (1) IT1221940B (fr)
LU (1) LU86938A1 (fr)
NL (1) NL194961C (fr)
OA (1) OA08629A (fr)
PT (1) PT85247B (fr)
SE (1) SE506421C2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
GB2192185B (en) * 1986-07-03 1991-01-16 Genetic Systems Corp Monoclonal antibodies to pseudomonas aeruginosa flagella
CA1341375C (fr) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions pour le traitement et la prevention d'infections dues a des bacteries gram negatif, ainsi que leurs methodes d'utilisation
JPH02299594A (ja) * 1989-01-30 1990-12-11 Sumitomo Chem Co Ltd ヒトモノクローナル抗体およびその製法
WO1990013033A1 (fr) * 1989-04-14 1990-11-01 Biocontrol Systems, Incorporated Procede et dispositif de detection d'organismes mobiles particuliers
DE69131861T2 (de) * 1990-01-18 2000-05-18 Cura Nominees Pty Ltd Glykoalkaloide
EP2393515A1 (fr) * 2009-02-04 2011-12-14 Kalobios Pharmaceuticals, Inc. Antibiotique en combinaison et thérapie antibiotique pour traiter une infection par pseudomonas aeruginosa
EP2542577A1 (fr) * 2010-03-01 2013-01-09 Lostam Biopharmaceuticals Ltd ANTICORPS THÉRAPEUTIQUES AMÉLIORÉS CONTRE PSEUDOMONAS AERUGINOSA À FLAGELLES& xA;

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422649D0 (en) * 1984-09-07 1984-10-10 Technology Licence Co Ltd Monoclonal antibodies
JP2691708B2 (ja) * 1984-09-26 1997-12-17 住友製薬株式会社 ヒトモノクローナル抗体およびその製法
AU5991786A (en) * 1985-06-06 1987-01-07 Genetic Systems Corporation Protective human monoclonal antibodies to pseudomonas aeruginosa exotoxin a
EP0211352B1 (fr) * 1985-08-01 1994-03-16 Miles Inc. Anticorps protecteurs contre des déterminants sérotypiques d'antigènes flagellaires
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
ZA868673B (en) * 1985-12-10 1988-07-27 Genetic Systems Corp Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
GB2192185B (en) * 1986-07-03 1991-01-16 Genetic Systems Corp Monoclonal antibodies to pseudomonas aeruginosa flagella

Also Published As

Publication number Publication date
ATA168387A (de) 1994-12-15
IL83047A0 (en) 1987-12-31
KR910002373B1 (ko) 1991-04-20
KR880001815A (ko) 1988-04-27
AU7495887A (en) 1988-01-07
FR2601458A1 (fr) 1988-01-15
JP2639422B2 (ja) 1997-08-13
PT85247B (pt) 1990-06-29
IE871769L (en) 1988-01-03
ES2013321A6 (es) 1990-05-01
LU86938A1 (fr) 1988-02-02
NL194961B (nl) 2003-05-01
NL194961C (nl) 2003-09-02
GB2192185A (en) 1988-01-06
IE60888B1 (en) 1994-08-24
DE3722098A1 (de) 1988-03-03
AT399885B (de) 1995-08-25
NL8701554A (nl) 1988-02-01
BE1000743A3 (fr) 1989-03-28
PT85247A (en) 1987-08-01
AU615162B2 (en) 1991-09-26
IT1221940B (it) 1990-08-31
GB2192185B (en) 1991-01-16
SE8702734D0 (sv) 1987-07-02
DE3722098C2 (de) 1998-06-04
GB8715347D0 (en) 1987-08-05
IT8721163A0 (it) 1987-07-02
IL83047A (en) 1992-12-01
SE506421C2 (sv) 1997-12-15
FR2601458B1 (fr) 1992-08-21
SE8702734L (sv) 1988-01-04
JPS63102697A (ja) 1988-05-07
DK336687D0 (da) 1987-06-30
DK172840B1 (da) 1999-08-09
OA08629A (en) 1988-11-30
DK336687A (da) 1988-01-04

Similar Documents

Publication Publication Date Title
AT400441B (de) Zell-linien und verfahren zur herstellung von humanen monoklonalen antikörpern sowie kit und verfahren zur bestimmung der anwesenheit von p.aeruginosa
DE60030274T2 (de) Aus ganzen zellen bestehender impfstoff, der staphylococcus aureus antigen enthält
DE60123036T2 (de) Anthrax-spezifisches antigen, impfstoffe die das antigen enthalten, anthrax-spezifische antikörper, und deren verwendungen
DE60026691T2 (de) Staphylococcus-antigene und impstoffe
FI111336B (fi) Menetelmä Staphylococcus epidermidis tyyppi I:n polysakkaridiantigeenin sisältävän rokotteen ja antigeeninvastaisen hyperimmunoglobuliinin valmistamiseksi
EP0418827B1 (fr) Vaccin contre la maladie de Lyme
JPH02283294A (ja) ヒトモノクローナル抗体
AT398781B (de) Unsterbliche zellinie und deren verwendung
US4834976A (en) Monoclonal antibodies to pseudomonas aeruginosa flagella
AT397803B (de) Humaner monoklonaler antikörper und hybridom zur herstellung desselben
DE69329642T3 (de) Breitreaktive opsonische antikörper die mit gemeinsamen antigenen von staphylococcus reagieren
CH677796A5 (fr)
AT391080B (de) Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
EP0537497A2 (fr) Anticorps monoclonaux contre mycoplasma pneumoniae, hybridomes les produisant, procédé pour leur préparation et leur application
DE3541044A1 (de) Neues, allgemein anwendbares antigen (psc-a) gegen pseudomonas aeruginosa, das als mittel zum schutz gegen pseudomonas aeruginosa-infektion wirkt
DE4493997C2 (de) Neue abgeschwächte Pseudomonas-Aeruginosa-Stämme
Marandi et al. Characterization of an outer membrane protein of Pasteurella multocida belonging to the OmpA family
JP4002187B2 (ja) 抗ふけ菌免疫抗体及びその用途
DE69932719T2 (de) Humanisierte Antikörper zur Erkennung von Verotoxin II sowie Zelllinie zur Herstellung derselben
DE69935323T2 (de) Moraxella catharralis proteine
AT395591B (de) Humaner monoklonaler antikoerper, verfahren zu dessen herstellung, arzneimittel und hybridzelle
AT390192B (de) Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen
EP0387850B1 (fr) Anticorps monoclonaux ECA-spécifiques et leur utilisation
JPH01193300A (ja) ヒトモノクローナル抗体およびその製法
DD286822A5 (de) Verfahren zur herstellung muriner monoklonaler antikoerper gegen das hauptstrukturprotein p24 des humanen immundefekt virus (hiv)

Legal Events

Date Code Title Description
PL Patent ceased